It has been reported that HCK has oncogenic potential in Philadelphia chromosome-positive (Ph+) leukemia and lymphoma cells [71, 72], however, other studies also demonstrated tumor suppressor functions for HCK in Ph− leukemias [73-75]. The gene discussed is HCK; the disease is lymphoma.